An injectable HIV treatment developed by British drugmaker GlaxoSmithKline is offering hope to patients in Uganda. Results of the WHO-approved trial are due in 2024.
#HIV #Uganda #Treatment #News #Reuters #newsfeed
Subscribe: [ Ссылка ]
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: [ Ссылка ]
Follow Reuters on Facebook: [ Ссылка ]
Follow Reuters on Twitter: [ Ссылка ]
Follow Reuters on Instagram: [ Ссылка ]
